Related Experiment Videos
Sisomicin in urinary tract infection: Tolerance and efficacy study
Urology
|February 1, 1976
Summary
Sisomicin effectively treated gram-negative urinary tract infections in 21 patients, achieving a 62% cure rate. Mild, temporary kidney function changes were noted in a few cases, with no other adverse effects observed.
Area of Science:
- Pharmacology
- Infectious Diseases
- Nephrology
Background:
- Gram-negative bacteria are common causes of urinary tract infections (UTIs).
- Aminoglycoside antibiotics are crucial for treating severe bacterial infections.
- Sisomicin is a novel aminoglycoside antibiotic with potential therapeutic applications.
Purpose of the Study:
- To evaluate the efficacy and safety of sisomicin in treating gram-negative UTIs.
- To determine the clinical outcomes and potential adverse effects of sisomicin therapy.
Main Methods:
- A clinical trial involving 21 patients diagnosed with gram-negative UTIs.
- Treatment administered with sisomicin, a new aminoglycoside antibiotic.
- Assessment of bacteriologic cure, clinical improvement, and patient safety.
Main Results:
- Bacteriologic cure was achieved in 62% of patients.
- Clinical improvement was observed in an additional 33% of patients.
- Mild, transient elevations in serum creatinine occurred in 3 patients, with no other significant toxicity.
Conclusions:
- Sisomicin demonstrates significant efficacy in treating gram-negative UTIs.
- The antibiotic appears well-tolerated, with minimal renal side effects.
- Further studies exploring optimized dosing and combination therapy are warranted.